Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials

著者: Jacques Donnez, Hugh S. Taylor, Elizabeth A. Stewart, Linda Bradley, Erica E. Marsh, David F. Archer, Ayman Al‐Hendy, Felice Petraglia, Nelson B. Watts, Jean‐Pierre Gotteland, Elke Bestel, Paul Terrill, Ernest Loumaye, Andrew Humberstone, Elizabeth Garner - The Lancet 2022 被引用: 72